120 results
424B5
ATXI
Avenue Therapeutics Inc
10 May 24
Prospectus supplement for primary offering
4:52pm
relating to defeasance;
provisions relating to satisfaction and discharge of the indenture;
any restrictions or conditions on the transferability
8-K
EX-4.2
ATXI
Avenue Therapeutics Inc
1 May 24
Avenue Therapeutics Announces Exercise of Warrants for $4.4 Million in Gross Proceeds
4:28pm
to deliver in satisfaction of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving upon such exercise (a “Buy
8-K
EX-4.3
ATXI
Avenue Therapeutics Inc
1 May 24
Avenue Therapeutics Announces Exercise of Warrants for $4.4 Million in Gross Proceeds
4:28pm
) or the Holder’s brokerage firm otherwise purchases, shares of Common Stock to deliver in satisfaction of a sale by the Holder of the Warrant Shares
8-K
EX-10.1
ATXI
Avenue Therapeutics Inc
1 May 24
Avenue Therapeutics Announces Exercise of Warrants for $4.4 Million in Gross Proceeds
4:28pm
) shares of Common Stock to deliver in satisfaction of a sale by the Holder of all or any portion of the number of shares of Common Stock, or a sale
8-K
EX-99.1
8ss79v05bad4k
1 May 24
Avenue Therapeutics Announces Exercise of Warrants for $4.4 Million in Gross Proceeds
4:28pm
8-K
EX-4.1
d0frbnc i9n
1 May 24
Avenue Therapeutics Announces Exercise of Warrants for $4.4 Million in Gross Proceeds
4:28pm
8-K
EX-99.1
bjy1bh1y3mul6rah3dl
8 Jan 24
Entry into a Material Definitive Agreement
5:28pm
8-K
EX-4.1
0ckzrc8
8 Jan 24
Entry into a Material Definitive Agreement
5:28pm
8-K
EX-10.2
lz35f jwrax5b
8 Jan 24
Entry into a Material Definitive Agreement
5:28pm
8-K
EX-4.2
orojyliv h3yzvfoyl
8 Jan 24
Entry into a Material Definitive Agreement
5:28pm
8-K
funyhro2tsimmo lgja
8 Jan 24
Entry into a Material Definitive Agreement
5:28pm
8-K
EX-10.1
7t2tym 0fed0scn
8 Jan 24
Entry into a Material Definitive Agreement
5:28pm
8-K
EX-10.2
xzgjkndm
2 Nov 23
Avenue Therapeutics Announces Pricing of $5.0 Million Public Offering
4:10pm
8-K
EX-4.2
6lxbybm j54e
2 Nov 23
Avenue Therapeutics Announces Pricing of $5.0 Million Public Offering
4:10pm
8-K
EX-10.1
u1a5o 111
2 Nov 23
Avenue Therapeutics Announces Pricing of $5.0 Million Public Offering
4:10pm
8-K
EX-4.1
ea7slyx0x89fbn
2 Nov 23
Avenue Therapeutics Announces Pricing of $5.0 Million Public Offering
4:10pm